Latest news

International Pricing Index is NOT an Answer to Health Care Costs
February 3, 2020 (Washington, D.C.) The Partnership to Fight Chronic Disease (PFCD) has released the following statement on the proposed international pricing index:   The Partnership to Fight Chronic Disease opposes proposed “international pricing index” models to address
Press release
Feb 3,2020
Don't legalize discrimination against people with disabilities
Kenneth E. Thorpe, Guest columnist 5:00 p.m. CT Jan. 14, 2020   Quality-adjusted life year cost-benefit analyses systemically undervalue the lives of patients with disabilities.   Imagine if the federal government treated disabled Americans as second-class citizens. It's an
OP-ED
Jan 15,2020
New Data Estimates Staggering Costs of Chronic Disease in Largest U.S. Metropolis
Congressional briefing examines how social determinants, health disparities impact America's hardest hit populations   December 12, 2019 (Washington, D.C.) Recent research data developed by IHS Markit on behalf of the Partnership to Fight Chronic Disease (PFCD) examines the enormous
Press release
Dec 12,2019
Health Care Valuations Based on QALY Undercut the Fight Against Chronic Disease
Ethical questions loom over innovative efforts that can save lives November 21, 2019 09:01 AM Eastern Standard Time WASHINGTON--(BUSINESS WIRE)--The Partnership to Fight Chronic Disease (PFCD) has released the following statement regarding the National Council
Press release
Nov 21,2019
Hospital Costs are #1 Driver of $101 Billion Increase in Private Health Insurance Spending
Better overall health, reduced chronic disease rates key to lowering health spending   November 19, 2019 11:37 AM Eastern Standard Time WASHINGTON--(BUSINESS WIRE)--The Partnership to Fight Chronic Disease (PFCD) has just released, “What Accounts for the Growth in Private Health
Press release
Nov 19,2019
Proposed Drug Price Reform Would Short-Change Rare Disease Patients
By Kenneth E. Thorpe October 10, 2019   A prominent healthcare watchdog has found the solution to high drug prices – or so it claims.   For years, the nonprofit Institute for Clinical and Economic Review (ICER) has analyzed and rated the cost-
OP-ED
Oct 10,2019
Trump Administration's Drug Rebate Reforms Are Long Overdue
By Kenneth E. Thorpe March 28, 2019   Every month, drug companies offer up nearly $13 billion in rebates and other discounts.  Patients don't see these savings at the drugstore, though. The supply chain all but ensures that discounts instead flow to
OP-ED
Apr 2,2019
Sharing Rebates on Diabetes Medicines Could Save People with Diabetes $3.7 Billion a Year
Widespread impact for patients, employers and health plans could also result in one million fewer hospitalizations March 12, 2019 09:09 AM Eastern Daylight Time WASHINGTON--(BUSINESS WIRE)--A new study released today by the Partnership to Fight Chronic Disease (
Press release
Mar 12,2019
Another Voice: Trump's new Medicare rule would undermine patient protections
January 21, 2019   By Kenneth E. Thorpe   The Trump administration is poised to undermine seniors’ access to lifesaving medications.   It recently proposed a rule that would weaken patient protections within Medicare’s “Part D” prescription drug benefit
In the news
Feb 8,2019
Trump proposal could delay critical medications for Medicare patients
  January 25, 2019   About 40 million Medicare beneficiaries suffer from at least two chronic diseases. A new proposal from the Trump administration could result in worse outcomes for their conditions.   In an effort to reduce drug spending, the Department of
In the news
Feb 8,2019

Pages